Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2110-5820
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis ; volume:8 ; number:1 ; day:31 ; month:1 ; year:2018 ; pages:1-11 ; date:12.2018
Annals of intensive care ; 8, Heft 1 (31.1.2018), 1-11, 12.2018
- Schlagwort
-
Infektion
Infektiologie
- Urheber
-
Annane, Djillali
- Beteiligte Personen und Organisationen
-
Mira, Jean-Paul
Ware, Lorraine B.
Gordon, Anthony C.
Hinds, Charles J.
Christiani, David C.
Sevransky, Jonathan
Barnes, Kathleen
Buchman, Timothy G.
Heagerty, Patrick J.
Balshaw, Robert
Lesnikova, Nadia
Nobrega, Karen de
Wellman, Hugh F.
Neira, Mauricio
Mancini, Alexandra D. J.
Walley, Keith R.
Russell, James A.
SpringerLink (Online service)
- DOI
-
10.1186/s13613-018-0353-2
- URN
-
urn:nbn:de:1111-201803281910
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Annane, Djillali
- Mira, Jean-Paul
- Ware, Lorraine B.
- Gordon, Anthony C.
- Hinds, Charles J.
- Christiani, David C.
- Sevransky, Jonathan
- Barnes, Kathleen
- Buchman, Timothy G.
- Heagerty, Patrick J.
- Balshaw, Robert
- Lesnikova, Nadia
- Nobrega, Karen de
- Wellman, Hugh F.
- Neira, Mauricio
- Mancini, Alexandra D. J.
- Walley, Keith R.
- Russell, James A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Discovering biomarkers of drug efficacy in cancer from pharmacogenomic data
Pediatric Sepsis Biomarkers
Design, conduct, and analysis of a multicenter, pharmacogenomic, biomarker study in matched patients with severe sepsis treated with or without drotrecogin Alfa (activated)
Pharmacogenomic Biomarkers for Improved Drug Therapy—Recent Progress and Future Developments
Sepsis biomarkers: a review
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
Combining renal cell arrest and damage biomarkers to predict progressive AKI in patient with sepsis
Biomarkers of endothelial dysfunction predict sepsis mortality in young infants: a matched case-control study
Biomarkers for sepsis: an unfinished journey
Sepsis biomarkers: past, present and future
Comprehensive pharmacogenomic characterization of gastric cancer
Identification of Pharmacogenomic and Functional Biomarkers for Antidepressant Treatment Outcome in Patients-Derived Lymphoblastoid Cell Lines
Discovering biomarkers of drug efficacy in cancer from pharmacogenomic data
Pediatric Sepsis Biomarkers
Design, conduct, and analysis of a multicenter, pharmacogenomic, biomarker study in matched patients with severe sepsis treated with or without drotrecogin Alfa (activated)
Pharmacogenomic Biomarkers for Improved Drug Therapy—Recent Progress and Future Developments
Sepsis biomarkers: a review
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
Combining renal cell arrest and damage biomarkers to predict progressive AKI in patient with sepsis
Biomarkers of endothelial dysfunction predict sepsis mortality in young infants: a matched case-control study
Biomarkers for sepsis: an unfinished journey
Sepsis biomarkers: past, present and future
Comprehensive pharmacogenomic characterization of gastric cancer
Identification of Pharmacogenomic and Functional Biomarkers for Antidepressant Treatment Outcome in Patients-Derived Lymphoblastoid Cell Lines
Discovering biomarkers of drug efficacy in cancer from pharmacogenomic data
Pediatric Sepsis Biomarkers
Design, conduct, and analysis of a multicenter, pharmacogenomic, biomarker study in matched patients with severe sepsis treated with or without drotrecogin Alfa (activated)
Pharmacogenomic Biomarkers for Improved Drug Therapy—Recent Progress and Future Developments
Sepsis biomarkers: a review
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
Combining renal cell arrest and damage biomarkers to predict progressive AKI in patient with sepsis
Biomarkers of endothelial dysfunction predict sepsis mortality in young infants: a matched case-control study
Biomarkers for sepsis: an unfinished journey
Sepsis biomarkers: past, present and future
Comprehensive pharmacogenomic characterization of gastric cancer